文献速递脑血管病

COVID-19大流行期间儿童动脉缺血性卒中的SARS-CoV-2国际患病率及机制

International Prevalence and Mechanisms of SARS-CoV-2 in Childhood Arterial Ischemic Stroke During the COVID-19 Pandemic.
PubMed 文献 · Stroke · 2022-04-05

该研究调查了2020年6月至12月全球61个中心的儿童动脉缺血性卒中(AIS)数据,发现住院SARS-CoV-2患儿中AIS发生率为0.32%,与早期估计的0.62%相比无显著差异(P=0.14)。在SARS-CoV-2检测阳性的AIS患儿中,6.9%为阳性,与早期6.1%相近(P=0.78)。SARS-CoV-2被认为是主要卒中风险因素的患儿中,炎症性动脉病变是卒中机制。

要点

  • 住院SARS-CoV-2患儿中AIS发生率为0.32%,与早期0.62%相比无显著差异(P=0.14)。
  • 急性AIS患儿SARS-CoV-2检测率为89.8%,较早期59.6%提高(P<0.0001)。
  • SARS-CoV-2阳性AIS患儿中,炎症性动脉病变是主要卒中机制。

核心结论

  • 住院SARS-CoV-2患儿中AIS风险与早期估计相比似乎稳定。
  • 在SARS-CoV-2被认为是主要卒中风险因素的患儿中,炎症性动脉病变是卒中机制。

研究设计与样本

  • 国际多中心调查,纳入21个国家61个中心,调查2020年6月1日至12月31日住院SARS-CoV-2患儿及儿童AIS病例。
  • 由两名卒中神经科医生和一名神经放射科医生判定SARS-CoV-2为主要卒中风险因素、促进因素或偶然因素。

主要发现

  • 48个中心(78.7%)提供了SARS-CoV-2住院数据。
  • 335/373例急性AIS病例(89.8%)进行了SARS-CoV-2检测,而2020年3月至5月为99/166例(59.6%),P<0.0001。
  • 335例检测的AIS病例中23例(6.9%)SARS-CoV-2阳性,而2020年3月至5月为6/99例(6.1%),P=0.78。
  • 在可收集额外数据的22例SARS-CoV-2阳性AIS病例中,SARS-CoV-2为主要卒中风险因素6例(3例动脉炎/血管炎,3例局灶性脑动脉病),促进因素13例,偶然因素3例。
  • 炎症标志物升高常见,发生在17例(77.3%)中。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data from the early pandemic revealed that 0.62% of children hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had an acute arterial ischemic stroke (AIS). In a larger cohort from June 2020 to December 2020, we sought to determine whether our initial point estimate was stable as the pandemic continued and to understand radiographic and laboratory data that may clarify mechanisms of pediatric AIS in the setting of SARS-CoV-2. METHODS: We surveyed international sites with pediatric stroke expertise to determine numbers of hospitalized SARS-CoV-2 patients <18 years, numbers of incident AIS cases among children (29 days to <18 years), frequency of SARS-CoV-2 testing for children with AIS, and numbers of childhood AIS cases positive for SARS-CoV-2 June 1 to December 31, 2020. Two stroke neurologists with 1 neuroradiologist determined whether SARS-CoV-2 was the main stroke risk factor, contributory, or incidental. RESULTS: Sixty-one centers from 21 countries provided AIS data. Forty-eight centers (78.7%) provided SARS-CoV-2 hospitalization data. SARS-CoV-2 testing was performed in 335/373 acute AIS cases (89.8%) compared with 99/166 (59.6%) in March to May 2020, P<0.0001. Twenty-three of 335 AIS cases tested (6.9%) were positive for SARS-CoV-2 compared with 6/99 tested (6.1%) in March to May 2020, P=0.78. Of the 22 of 23 AIS cases with SARS-CoV-2 in whom we could collect additional data, SARS-CoV-2 was the main stroke risk factor in 6 (3 with arteritis/vasculitis, 3 with focal cerebral arteriopathy), a contributory factor in 13, and incidental in 3. Elevated inflammatory markers were common, occurring in 17 (77.3%). From centers with SARS-CoV-2 hospitalization data, of 7231 pediatric patients hospitalized with SARS-CoV-2, 23 had AIS (0.32%) compared with 6/971 (0.62%) from March to May 2020, P=0.14. CONCLUSIONS: The risk of AIS among children hospitalized with SARS-CoV-2 appeared stable compared with our earlier estimate. Among children in whom SARS-CoV-2 was considered the main stroke risk factor, inflammatory arteriopathies were the stroke mechanism.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Beslow LA, Agner SC, Santoro JD, et al. International Prevalence and Mechanisms of SARS-CoV-2 in Childhood Arterial Ischemic Stroke During the COVID-19 Pandemic. Stroke. 2022. PMID: 35380052. doi:10.1161/STROKEAHA.121.038250

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。